Back

Sight Sciences Inc

Ticker: SGHT ISIN: US82657M1053
Add to portfolio Portfolio analysis in 2min
Stock Small-cap High beta Trading above 200-day average Near 52-week high
Market cap
$195.04M
Forward P/E
0.00
Profit margin
-63.30%
Revenue growth QoQ
0.70%
Beta
2.73
$8.38 1.45%
Price as of 2026-08-24 · NASDAQ

Performance by timeframe

Rolling returns
1 Month +63.67%
6 Months +59.62%
1 Year +99.05%
5 Years -24.48% p.a.-75.41%
Since inception -23.76% p.a.-74.99%
Calendar year returns
YTD +5.67%
2025 +117.86%
2024 -29.46%
2023 -57.74%
2022 -30.51%

Key stats

Market cap
195.04M
Beta
2.73
52-week range
2.71 - 8.45
50-day MA
4.92
200-day MA
5.76
Section 1

Business overview

Company profile data from fundamentals.

Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. It operates through two segments, Surgical Glaucoma and Dry Eye. The company's products include OMNI Surgical System, an implant-free glaucoma surgery technology indicated to reduce intraocular pressure in adult patients with primary open-angle glaucoma; and SION Surgical Instrument, a manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. It also offers TearCare System, a wearable eyelid technology for adult patients with evaporative dry eye disease due to meibomian gland dysfunction, as well as related components. It offers its products through sales representatives and distributors to hospitals, medical centers, and eyecare professionals in the United States. Sight Sciences, Inc. was incorporated in 2010 and is headquartered in Menlo Park, California.

Sector Healthcare
Industry Medical Devices
Country United States
Exchange NASDAQ
Section 2

Financial quality

Above-average volatility

Profitability and balance-sheet quality indicators from reported fundamentals.

Profitability

ROE -45.36%
ROA -19.41%
Profit margin -63.30%
Operating margin -55.71%
Revenue/share TTM 1.60
Revenue TTM 79.54M
EBITDA -49.02M
Gross profit TTM 58.97M
Beta 2.73

Valuation

Trailing P/E 0.00
Forward P/E 0.00
P/B 2.05
P/S 2.45
EV/EBITDA -4.25
EV/Revenue 1.41
Section 3

Earnings

Earnings metrics from company highlights and earnings datasets.

EPS estimate (current year) -0.91
Quarterly earnings growth 0.00%
Revenue TTM 79.54M
Reported quarters 19
Section 4

Dividends & corporate actions

Dividend and split fields from fundamentals.

Forward annual div. yield 0.00%
Last split date 0000-00-00
Section 5

Ownership / analyst view

Institutional ownership and analyst estimate fields when available.

Analyst

Analyst target price $4.63
Analyst rating 3.2857

Ownership & short interest

Shares outstanding 50.40M
Shares float 31.08M
Institutional ownership 51.10%
Insider ownership 20.42%
Short ratio 4.06
Short % of float 2.65%

Details

Instrument metadata and source update timestamps.

Symbol SGHT
Name Sight Sciences Inc
Asset type STOCK
Exchange NASDAQ
Currency USD
ISIN US82657M1053
Country USA
Code + exchange SGHT.NASDAQ
Fundamentals updated 2024-12-08

The information provided on this platform is for informational purposes only and should not be considered as financial or investment advice. Insightfolio does not provide investment advice, personalized recommendations, or guidance regarding the purchase, holding, or sale of financial assets. The tools and content are intended for educational purposes only and are not tailored to individual circumstances, financial needs, or objectives.

Insightfolio assumes no liability for the accuracy, completeness, or reliability of the information presented. Users are solely responsible for verifying the information and making independent decisions based on their own research and careful consideration. Use of the platform should not replace consultation with qualified financial professionals.

Investments involve risks. Users should be aware that the value of investments may fluctuate and that past performance is not an indicator of future results. Investment decisions should be based on personal financial goals, risk tolerance, and independent evaluation of relevant information.

Insightfolio does not endorse or guarantee the suitability of any particular financial product, security, or strategy. Any projections, forecasts, or hypothetical scenarios presented on the platform are for illustrative purposes only and are not guarantees of future outcomes.

By accessing the services, information, or content offered by Insightfolio, users acknowledge and agree to these terms of the disclaimer. If you do not agree to these terms, please do not use our platform.

Instrument logos provided by Elbstream.